← FDA DRUG APPROVALS

FDA ANDA · ANDA074407

CLOBETASOL PROPIONATE

Sponsor: FOUGERA PHARMS

APPLICATION
ANDA074407
TYPE
ANDA
ORIGINAL APPROVAL
1996-02-23
LATEST ACTION
2006-08-14
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · OINTMENT · TOPICAL

Approval history

2006-08-14Labeling · Supplement 7AP
2001-03-05Labeling · Supplement 3AP
2001-03-05Manufacturing (CMC) · Supplement 4AP
1997-12-15Labeling · Supplement 1AP
1997-05-08Labeling · Supplement 2AP
1996-02-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →